Physician profile
George A Paletta
NPI 1497720825
$30,177.45
in general payments reported to CMS, 2019-2025
8 companies · $2,318 in 2025
The $2,318 reported for 2025 was more than what 91% of Neuromusculoskeletal Medicine, Sports Medicine providers received nationally (typical 2025 total: $125).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $1,490 · 2021: $5,685 · 2022: $2,564 · 2023: $3,412 · 2024: $3,825 · 2025: $2,318.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $5,447 · Travel and Lodging: $2,137 · Food and Beverage: $1,971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $5,447.02 |
| Travel and Lodging | $2,136.97 |
| Food and Beverage | $1,970.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $25,989.12 | 2019-2025 | Arthrex |
| Elite Orthopedics, LLC | $3,001.23 | 2019-2025 | |
| Zimmer Biomet Holdings, INC. | $408.91 | 2019-2020 | |
| Gotham Surgical Solutions & Devices, INC. | $407.00 | 2022-2024 | |
| Stryker Corporation | $172.80 | 2025 | Mako |
| Smith+Nephew, INC. | $163.51 | 2019-2025 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Fidia Pharma USA INC. | $18.73 | 2023 | Triluron, Hymovis |
| Depuy Synthes Sales INC. | $16.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Paletta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.